Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price traded up 12.8% during trading on Wednesday . The company traded as high as GBX 7.05 and last traded at GBX 7.05. 496,768 shares traded hands during mid-day trading, an increase of 249% from the average session volume of 142,462 shares. The stock had previously closed at GBX 6.25.
Abingdon Health Stock Performance
The stock’s 50-day moving average price is GBX 6.06 and its 200 day moving average price is GBX 6.25. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company has a market cap of £17.37 million, a P/E ratio of -9.59 and a beta of 0.13.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
See Also
- Five stocks we like better than Abingdon Health
- What is Forex and How Does it Work?
- OpenAI’s Restructuring Sets up What Could Be the Biggest IPO Ever
- What is the Hang Seng index?
- 2 Rare Earth Stocks the U.S. Government Doesn’t Want to Fail
- The Most Important Warren Buffett Stock for Investors: His Own
- CrowdStrike Partners With CoreWeave But Investors Sell the News
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
